Since 2014, Biosimilars Review & Report (www.biosimilarsrr.com) has provided education, commentary, consulting, and updates on the biosimilar industry, with a spotlight on developments affecting the U.S. biosimilar marketplace. Our content includes drug research and clinical trial development, FDA submissions and approvals, payer coverage of biosimilars, and reports from biosimilar-focused conferences